83 FR 5711 - Cyflufenamid; Pesticide Tolerances
ENVIRONMENTAL PROTECTION AGENCY Federal Register Volume 83, Issue 28 (February 9, 2018)
Federal Register Volume 83, Issue 28 (February 9, 2018)
| Page Range | 5711-5717 | |
| FR Document | 2018-02670 |
[Federal Register Volume 83, Number 28 (Friday, February 9, 2018)] [Rules and Regulations] [Pages 5711-5717] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-02670] ======================================================================= ----------------------------------------------------------------------- ENVIRONMENTAL PROTECTION AGENCY 40 CFR Part 180 [EPA-HQ-OPP-2016-0649; FRL-9972-61] Cyflufenamid; Pesticide Tolerances AGENCY: Environmental Protection Agency (EPA). ACTION: Final rule. ----------------------------------------------------------------------- SUMMARY: This regulation establishes tolerances for residues of cyflufenamid in or on cherry crop subgroup 12-12A, hops dried cones, and fruiting vegetable crop group 8-10; and amends the tolerance for cucurbit vegetable crop group 9. Nisso America, on behalf of Nippon Soda Co., Ltd. requested these tolerances under the Federal Food, Drug, and Cosmetic Act (FFDCA). DATES: This regulation is effective February 9, 2018. Objections and requests for hearings must be received on or before April 10, 2018, and must be filed in accordance with the instructions provided in 40 CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION). ADDRESSES: The docket for this action, identified by docket identification (ID) number EPA-HQ-OPP-2016-0649, is available at http://www.regulations.gov or at the Office of Pesticide Programs [[Page 5712]] Regulatory Public Docket (OPP Docket) in the Environmental Protection Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW, Washington, DC 20460-0001. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is (202) 566-1744, and the telephone number for the OPP Docket is (703) 305-5805. Please review the visitor instructions and additional information about the docket available at http://www.epa.gov/dockets. FOR FURTHER INFORMATION CONTACT: Michael Goodis, Registration Division (7505P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; main telephone number: (703) 305-7090; email address: RDFRNotices@epa.gov. SUPPLEMENTARY INFORMATION: I. General Information A. Does this action apply to me? You may be potentially affected by this action if you are an agricultural producer, food manufacturer, or pesticide manufacturer. The following list of North American Industrial Classification System (NAICS) codes is not intended to be exhaustive, but rather provides a guide to help readers determine whether this document applies to them. Potentially affected entities may include:Crop production (NAICS code 111). Animal production (NAICS code 112). Food manufacturing (NAICS code 311). Pesticide manufacturing (NAICS code 32532). B. How can I get electronic access to other related information? You may access a frequently updated electronic version of EPA's tolerance regulations at 40 CFR part 180 through the Government Printing Office's e-CFR site at http://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl C. How can I file an objection or hearing request? Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an objection to any aspect of this regulation and may also request a hearing on those objections. You must file your objection or request a hearing on this regulation in accordance with the instructions provided in 40 CFR part 178. To ensure proper receipt by EPA, you must identify docket ID number EPA-HQ-OPP-2016-0649 in the subject line on the first page of your submission. All objections and requests for a hearing must be in writing, and must be received by the Hearing Clerk on or before April 10, 2018. Addresses for mail and hand delivery of objections and hearing requests are provided in 40 CFR 178.25(b). In addition to filing an objection or hearing request with the Hearing Clerk as described in 40 CFR part 178, please submit a copy of the filing (excluding any Confidential Business Information (CBI)) for inclusion in the public docket. Information not marked confidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA without prior notice. Submit the non-CBI copy of your objection or hearing request, identified by docket ID number EPA-HQ-OPP-2016-0649, by one of the following methods: Federal eRulemaking Portal: http://www.regulations.gov. Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be CBI or other information whose disclosure is restricted by statute. Mail: OPP Docket, Environmental Protection Agency Docket Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC 20460-0001. Hand Delivery: To make special arrangements for hand delivery or delivery of boxed information, please follow the instructions at http://www.epa.gov/dockets/contacts.html. Additional instructions on commenting or visiting the docket, along with more information about dockets generally, is available at http://www.epa.gov/dockets. II. Summary of Petitioned-For Tolerance In the Federal Register of March 23, 2017 (82 FR 14846) (FRL-9957- 99), EPA issued a document pursuant to FFDCA section 408(d)(3), 21 U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP 6F8512) by Nisso America on behalf of Nippon Soda Co., Ltd., 88 Pine Street, 14th Floor, New York, NY 10005. The petition requested that 40 CFR 180.667 be amended by establishing tolerances for residues of the fungicide cyflufenamid, in or on cherry crop subgroup 12-12A at 0.6 parts per million (ppm), hops at 5.0 ppm, and fruiting vegetable crop group 8-10 at 0.2 ppm. Then in the Federal Register of September 15, 2017 (82 FR 43352) (FRL-9965-43), EPA issued another document pursuant to FFDCA section 408(d)(3), 21 U.S.C. 346a(d)(3), announcing that this petition also requested the amendment of the existing tolerance for residues of cyflufenamid in or on cucurbit vegetable group 9, increasing the tolerance level from 0.07 ppm to 0.10 ppm. Those documents referenced a summary of the petition prepared by Nisso America on behalf of Nippon Soda Co., Ltd., the registrant, which is available in the docket, http://www.regulations.gov. Comments were received on the notices of filing. EPA's response to these comments is discussed in Unit IV.C. III. Aggregate Risk Assessment and Determination of Safety Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a tolerance (the legal limit for a pesticide chemical residue in or on a food) only if EPA determines that the tolerance is ``safe.'' Section 408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a reasonable certainty that no harm will result from aggregate exposure to the pesticide chemical residue, including all anticipated dietary exposures and all other exposures for which there is reliable information.'' This includes exposure through drinking water and in residential settings, but does not include occupational exposure. Section 408(b)(2)(C) of FFDCA requires EPA to give special consideration to exposure of infants and children to the pesticide chemical residue in establishing a tolerance and to ``ensure that there is a reasonable certainty that no harm will result to infants and children from aggregate exposure to the pesticide chemical residue. . . .'' Consistent with FFDCA section 408(b)(2)(D), and the factors specified in FFDCA section 408(b)(2)(D), EPA has reviewed the available scientific data and other relevant information in support of this action. EPA has sufficient data to assess the hazards of and to make a determination on aggregate exposure for cyflufenamid including exposure resulting from the tolerances established by this action. EPA's assessment of exposures and risks associated with cyflufenamid follows. A. Toxicological Profile EPA has evaluated the available toxicity data and considered its validity, completeness, and reliability as well as the relationship of the results of the studies to human risk. EPA has also considered available information concerning the variability of the sensitivities of major identifiable subgroups of consumers, including infants and children. Cyflufenamid has low acute toxicity via the oral, dermal, and inhalation routes of exposure. Though slightly irritating to the eye, cyflufenamid is not [[Page 5713]] a skin irritant or sensitizer. In the mammalian toxicology database, the liver was the primary target organ for cyflufenamid toxicity. Across species, duration and gender, changes in weight, clinical chemistry, and pathology indicated treatment-related perturbations in and adverse effects on liver function. Thyroid effects due to treatment with cyflufenamid, seen only in the rat, included increased follicular cell hypertrophy (as well as increased organ weight) and neoplastic thyroid follicular adenomas. Kidney effects related to treatment included increased kidney weight accompanied by tubular vacuolation and slight decreases in sodium and chloride concentrations. Treatment-related cardiotoxicity was noted in the rat and mouse feeding studies. Observed myocardial vacuolation and lipidosis may be attributed to decreased lipid metabolism; cyflufenamid caused an approximately 50% inhibition of carnitine palmitoyltransferase in both rat and mouse heart microsomal fractions in a non-guideline mechanistic study. Carnitine palmitoyltransferase is involved in the transport of long chain fatty acids into the mitochondrial matrix for oxidation. Fatty acid oxidation is an important source of energy for adenosine triphosphate (ATP) production in the mitochondria. Cyflufenamid-induced brain vacuolation was specific to the dog and not associated with any apparent clinical sign of neurotoxicity. Supplementary studies investigating this phenomenon determined that vacuolation was due to myelin edema affecting the white matter of the cerebrum and thalamus. Furthermore, this brain lesion was partially reversed after a 13-week recovery period (following 90-day exposure) and fully reversed after a 26-week recovery period. This effect was not observed in any other species. A subchronic neurotoxicity study in rats showed no evidence of neurotoxicity. Effects on reproductive organs and/or parameters have been previously noted in several subchronic studies; however, the effects occurred at doses above the respective lowest observed adverse effect level (LOAELs) from the studies used to derive the point of departures (POD)s. The PODs are protective of these effects. The developmental studies in rats and rabbits do not indicate any concern for increased susceptibility to offspring. Although offspring effects of decreased body weight and incomplete ossification were observed in rabbits, those effects occurred at doses higher than doses resulting in maternal effects and are believed to be related to maternal toxicity. Furthermore, the current PODs are protective of the effects seen on reproductive parameters in offspring. In addition, mating performance and fertility in the Parent/Filial (P/F) 0 generation were both unaffected by treatment with cyflufenamid in the 2-generation reproductive toxicity study in rats. Sex ratio, sexual maturation, estrous cyclicity, sperm quantity and quality, mating performance and fertility, gestation and viability indices in the filial 1 (F1 ) generation were all unaffected by treatment. When tolerances were last established for cyflufenamid (77 FR 38204, June 27, 2012), EPA had classified cyflufenamid as ``likely to be carcinogenic to humans'' based on the presence of thyroid follicular cell tumors in male rats and liver tumors in male mice. Since that time, EPA has reevaluated the carcinogenic potential of cyflufenamid and based on available data has reclassified cyflufenamid as having ``suggestive evidence of carcinogenicity.'' A well-established non- mutagenic mode of action (MOA) for thyroid follicular cell tumors in male rats was tested and found acceptable. In summary, EPA has determined that because of the thyroid hormone imbalance, thyroid follicular cell tumors in male rats are likely to occur. That lead to an increase in the size (hypertrophy) and number (hyperplasia) of the thyroid follicular cells and eventually to thyroid neoplasia (or tumors). Because of marked quantitative differences between rats and humans in their inherent susceptibility for thyroid tumors in response to an imbalance in thyroid hormones, EPA concludes that cyflufenamid is not likely to pose a risk for thyroid follicular cell tumors in humans. As a result, the database contains the following data concerning carcinogenicity: (1) There is no evidence of carcinogenicity in female rats and mice; (2) the MOA data indicates that thyroid follicular cell tumors may not be relevant to humans; (3) tumors were only found in the liver in one gender of one species, i.e., male mice; and (4) there is no concern for mutagenicity or clastogenicity based on the results of the battery of genotoxicity studies. Therefore, EPA concludes that the chronic reference dose (cRfD) (0.044 mg/kg/day) will adequately account for all chronic toxicity, including carcinogenicity (which occurred only at a dose over 5000x higher than the cRfD) that could result from exposure to cyflufenamid. Specific information on the studies received and the nature of the adverse effects caused by cyflufenamid as well as the no-observed- adverse-effect-level (NOAEL) and the LOAEL from the toxicity studies can be found at http://www.regulations.gov in document: ``Cyflufenamid. Human Health Risk Assessment for Proposed Uses on Fruiting Vegetable Group 8-10, Cherry crop Subgroup 12-12A, and Hops; and a Revised Tolerance on Cucurbit Vegetable Group 9'' on page 16 in docket ID number EPA-HQ-OPP-2016-0649. B. Toxicological Points of Departure/Levels of Concern Once a pesticide's toxicological profile is determined, EPA identifies toxicological POD and levels of concern to use in evaluating the risk posed by human exposure to the pesticide. For hazards that have a threshold below which there is no appreciable risk, the toxicological POD is used as the basis for derivation of reference values for risk assessment. PODs are based on a careful analysis of each toxicological study to determine the values of the NOAEL and the LOAEL. Uncertainty/safety factors are used in conjunction with the POD to calculate a safe exposure level--generally referred to as a population-adjusted dose (PAD) or a reference dose (RfD)--and a safe margin of exposure (MOE). For non-threshold risks, the Agency assumes that any amount of exposure will lead to some degree of risk. Thus, the Agency estimates risk in terms of the probability of an occurrence of the adverse effect expected in a lifetime. For more information on the general principles EPA uses in risk characterization and a complete description of the risk assessment process, see http://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/assessing-human-health-risk-pesticides. A summary of the toxicological endpoints for cyflufenamid used for human risk assessment is shown in the Table of this unit. Table Summary of Points of Departure and Toxicity Endpoints Used in Human Risk Assessment [[Page 5714]] Table--Summary of Toxicological Doses and Endpoints for Cyflufenamid for Use in Dietary, Non-Occupational and Occupational Human Health Risk Assessments ---------------------------------------------------------------------------------------------------------------- Uncertainty/ RfD, PAD, level Exposure/ scenario Point of FQPA safety of concern for Study and toxicological departure factors risk dssessment effects ---------------------------------------------------------------------------------------------------------------- Acute Dietary (All There were no appropriate toxicological effects attributable to a single exposure Populations). (dose) observed in appropriate toxicity studies. Therefore, a dose and endpoint were not identified for this risk assessment. ---------------------------------------------------------------------------------------------------------------- Chronic Dietary (All NOAEL = 4.4 mg/ UFA = 10x Chronic RfD = Combined Chronic Toxicity/ Populations). kg/day UFH = 10x...... 0.044 mg/kg/ Carcinogenicity Study in FQPA SF = 1x... day Rats. cPAD = 0.044 mg/ LOAEL = 22 mg/kg/day based on kg/day. increased thyroid/parathyroid weight, increased liver weight and centrilobular hepatocytic hypertrophy. ---------------------------------------------------------------------------------------------------------------- Dermal Short-Term (1-30 days) No adverse effects were observed in the dermal toxicity study and there are no and Intermediate-Term (1-6 concerns for developmental or neurological toxicities; therefore, no hazards are months). expected from these exposure scenarios. ---------------------------------------------------------------------------------------------------------------- Inhalation Short-Term (1-30 NOAEL = 5 mg/kg/ UFA = 10x Residential/ Prenatal Developmental Study days) and Intermediate-Term day UFH = 10x...... Occupational in Rabbits. (1-6 months). FQPA SF = 1x... LOC for MOE = Maternal LOAEL = 10 mg/kg/day 100 based on decreased body weight, body weight gains and food consumption. ---------------------------------------------------------------------------------------------------------------- Cancer (oral, dermal, Classification: ``Suggestive evidence of carcinogenic potential'' and inhalation). quantification of risk using a non-linear approach (i.e., RfD approach) is appropriate. ---------------------------------------------------------------------------------------------------------------- Point of Departure (POD) = A data point or an estimated point that is derived from observed dose-response data and used to mark the beginning of extrapolation to determine risk associated with lower environmentally relevant human exposures. NOAEL = no observed adverse effect level. LOAEL = lowest observed adverse effect level. UF = uncertainty factor. UFA = extrapolation from animal to human (interspecies). UFH = potential variation in sensitivity among members of the human population (intraspecies). FQPA SF = FQPA Safety Factor. PAD = population adjusted dose (a = acute, c = chronic). RfD = reference dose. MOE = margin of exposure. LOC = level of concern. C. Exposure Assessment 1. Dietary exposure from food and feed uses. In evaluating dietary exposure to cyflufenamid, EPA considered exposure under the petitioned- for tolerances as well as all existing cyflufenamid tolerances in 40 CFR 180.667. EPA assessed dietary exposures from cyflufenamid in food as follows: i. Acute exposure. Quantitative acute dietary exposure and risk assessments are performed for a food-use pesticide, if a toxicological study has indicated the possibility of an effect of concern occurring as a result of a 1-day or single exposure. No such effects were identified in the toxicological studies for cyflufenamid; therefore, a quantitative acute dietary exposure assessment is unnecessary. ii. Chronic exposure. In conducting the chronic dietary exposure assessment EPA used the food consumption data from the U.S. Department of Agriculture's National Health and Nutrition Examination Survey, What We Eat in America (USDA's NHANES/WWEIA). As to residue levels in food, EPA assumed tolerance-level residues and 100% crop treated (100% CT) for all commodities. iii. Cancer. Based on the data summarized in Unit III.A., EPA has concluded that a nonlinear RfD approach is appropriate for assessing cancer risk to cyflufenamid. Cancer risk was assessed using the same exposure estimates as discussed in Unit III.C.1.ii., chronic exposure. iv. Anticipated residue and percent crop treated (PCT) information. EPA did not use anticipated residue and PCT information in the dietary assessment for cyflufenamid. Tolerance-level residues and 100% CT were assumed for all food commodities. 2. Dietary exposure from drinking water. The Agency used screening- level water exposure models in the dietary exposure analysis and risk assessment for cyflufenamid in drinking water. These simulation models take into account data on the physical, chemical, and fate/transport characteristics of cyflufenamid. Further information regarding EPA drinking water models used in pesticide exposure assessment can be found at http://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/about-water-exposure-models-used-pesticide. The Agency used Tier II surface water and Tier I ground water simulations for all proposed cyflufenamid uses and label modifications. The estimated drinking water concentrations (EDWCs) of cyflufenamid for chronic exposures are 1.15 parts per billion (ppb) for surface water and 29.6 ppb for ground water. Modeled estimates of drinking water concentrations were directly entered into the dietary exposure model. For acute dietary risk assessment, no toxic effects attributable to a single exposure to cyflufenamid have been identified; therefore, an acute reference dose (aRfD) has not been established and an acute dietary exposure assessment was not conducted. For chronic and cancer dietary risk assessments, the ground water concentration value of 29.6 ppb was used to assess the contribution to drinking water. 3. From non-dietary exposure. The term ``residential exposure'' is used in this document to refer to non-occupational, non-dietary exposure (e.g., for lawn and garden pest control, indoor pest control, termiticides, and flea and tick control on pets). Although the Agency previously assessed residential handler exposure and risk estimates from the use of cyflufenamid on ornamental use sites, the Agency now assumes that cyflufenamid is only used by commercial applicators based on labeling requiring handlers to use personal protective equipment (PPE). Therefore, the Agency concludes that there are no residential handler exposures to assess. The Agency has also determined that there are no post-application residential exposures to assess. Although there is a potential for residential dermal post-application exposure from the existing uses of cyflufenamid, there is no adverse systemic hazard via the dermal route of exposure. Moreover, there is no [[Page 5715]] incidental oral exposure expected from cyflufenamid use on ornamental plants. Therefore, the Agency has concluded that there are no residential exposure scenarios to aggregate with dietary exposures for cyflufenamid. Further information regarding EPA standard assumptions and generic inputs for residential exposures may be found at http://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/standard-operating-procedures-residential-pesticide. 4. Cumulative effects from substances with a common mechanism of toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when considering whether to establish, modify, or revoke a tolerance, the Agency consider ``available information'' concerning the cumulative effects of a particular pesticide's residues and ``other substances that have a common mechanism of toxicity.'' EPA has not found cyflufenamid to share a common mechanism of toxicity with any other substances, and cyflufenamid does not appear to produce a toxic metabolite produced by other substances. For the purposes of this tolerance action, therefore, EPA has assumed that cyflufenamid does not have a common mechanism of toxicity with other substances. For information regarding EPA's efforts to determine which chemicals have a common mechanism of toxicity and to evaluate the cumulative effects of such chemicals, see EPA's website at http://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides. D. Safety Factor for Infants and Children 1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA shall apply an additional tenfold (10X) margin of safety for infants and children in the case of threshold effects to account for prenatal and postnatal toxicity and the completeness of the database on toxicity and exposure unless EPA determines based on reliable data that a different margin of safety will be safe for infants and children. This additional margin of safety is commonly referred to as the Food Quality Protection Act Safety Factor (FQPA SF). In applying this provision, EPA either retains the default value of 10X, or uses a different additional safety factor when reliable data available to EPA support the choice of a different factor. 2. Prenatal and postnatal sensitivity. There is no evidence of susceptibility following in utero and/or postnatal exposure in the developmental toxicity studies in rats or rabbits, and in the 2- generation rat reproduction study. Neither the rat nor rabbit developmental studies identified teratogenic effects. The marginally higher incidence of incompletely ossified epiphyses and metacarpals/ phalanges seen in rabbits may be associated with low fetal weight and are indicative of delayed embryo-fetal development. The combined offspring effects of decreased body weight and incomplete ossification are believed to be related to the observed maternal toxicity. Furthermore, the PODs selected for all exposure scenarios are lower than those doses causing adverse effects in offspring. There are no residual uncertainties concerning pre- and postnatal toxicity and no neurotoxicity concerns. 3. Conclusion. EPA has determined that reliable data show the safety of infants and children would be adequately protected if the FQPA SF were reduced to 1X. That decision is based on the following findings: i. The toxicity database for cyflufenamid is complete. ii. There is no indication that cyflufenamid is a neurotoxic chemical and there is no need for a developmental neurotoxicity study or additional UFs to account for neurotoxicity. iii. There is no evidence that cyflufenamid results in increased susceptibility in in utero rats or rabbits in the prenatal developmental studies or in young rats in the 2-generation reproduction study. iv. There are no residual uncertainties identified in the exposure databases. The dietary food exposure assessments were performed based on 100% CT and tolerance-level residues. EPA made conservative (protective) assumptions in the ground and surface water modeling used to assess exposure to cyflufenamid in drinking water. These assessments will not underestimate the exposure and risks posed by cyflufenamid. E. Aggregate Risks and Determination of Safety EPA determines whether acute and chronic dietary pesticide exposures are safe by comparing aggregate exposure estimates to the acute population adjusted dose (aPAD) and chronic PAD (cPAD). For linear cancer risks, EPA calculates the lifetime probability of acquiring cancer given the estimated aggregate exposure. Short-, intermediate-, and chronic-term risks are evaluated by comparing the estimated aggregate food, water, and residential exposure to the appropriate PODs to ensure that an adequate MOE exists. 1. Acute risk. An acute aggregate risk assessment takes into account acute exposure estimates from dietary consumption of food and drinking water. No adverse effect resulting from a single oral exposure was identified and no acute dietary endpoint was selected. Therefore, cyflufenamid is not expected to pose an acute risk. 2. Chronic risk. Using the exposure assumptions described in this unit for chronic exposure, EPA has concluded that chronic exposure to cyflufenamid from food and water will utilize 2.8% of the cPAD for the general U.S. population and 6.1% for children 1-2 years old, the population group receiving the greatest exposure. Based on the explanation in Unit III.C.3., regarding the lack of residential use patterns, chronic residential exposure to residues of cyflufenamid is not expected. 3. Short-term risk. A short-term adverse effect was identified for inhalation and oral exposures; however, cyflufenamid is not registered for any use patterns that would result in short-term residential exposure. Short-term risk is assessed based on short-term residential exposure plus chronic dietary exposure. Because there is no short-term residential exposure and chronic dietary exposure has already been assessed under the appropriately protective cPAD (which is at least as protective as the POD used to assess short-term risk), no further assessment of short-term risk is necessary, and EPA relies on the chronic dietary risk assessment for evaluating short-term risk for cyflufenamid. 4. Intermediate-term risk. An intermediate-term adverse effect was identified; however, cyflufenamid is not registered for any use patterns that would result in intermediate-term residential exposure. Intermediate-term risk is assessed based on intermediate-term residential exposure plus chronic dietary exposure. Because there is no intermediate-term residential exposure and chronic dietary exposure has already been assessed under the appropriately protective cPAD (which is at least as protective as the POD used to assess intermediate-term risk), no further assessment of intermediate-term risk is necessary, and EPA relies on the chronic dietary risk assessment for evaluating intermediate-term risk for cyflufenamid. 5. Aggregate cancer risk for U.S. population. EPA has determined that quantification of risk using the RfD approach is appropriate and will adequately account for all chronic toxicity, including carcinogenicity, that could result from exposure to [[Page 5716]] cyflufenamid. Based on the conclusions of the chronic dietary assessment, EPA concludes that exposure to cyflufenamid is unlikely to pose an aggregate cancer risk. 6. Determination of safety. Based on these risk assessments, EPA concludes that there is a reasonable certainty that no harm will result to the general population, or to infants and children from aggregate exposure to cyflufenamid residues. IV. Other Considerations A. Analytical Enforcement Methodology Adequate enforcement methodology (High-Performance Liquid Chromatography Method with tandem mass spectrometry detection (LC/MS/ MS), Method No. RD-01307) is available to enforce the tolerance expression. The method may be requested from: Chief, Analytical Chemistry Branch, Environmental Science Center, 701 Mapes Rd., Ft. Meade, MD 20755-5350; telephone number: (410) 305-2905; email address: residuemethods@epa.gov. B. International Residue Limits In making its tolerance decisions, EPA seeks to harmonize U.S. tolerances with international standards whenever possible, consistent with U.S. food safety standards and agricultural practices. EPA considers the international maximum residue limits (MRLs) established by the Codex Alimentarius Commission (Codex), as required by FFDCA section 408(b)(4). The Codex Alimentarius is a joint United Nations Food and Agriculture Organization/World Health Organization food standards program, and it is recognized as an international food safety standards-setting organization in trade agreements to which the United States is a party. EPA may establish a tolerance that is different from a Codex MRL; however, FFDCA section 408(b)(4) requires that EPA explain the reasons for departing from the Codex level. The Codex has not established a MRL for cyflufenamid. C. Response to Comments Several comments were received on the publication. While some comments raised issues outside the scope of the FFDCA analysis, the remaining comments primarily expressed general concerns about the potential health effects of pesticides residues in or on food and one comment asked that the combined effects of multiple pesticides be considered on food commodities. None of the comments specifically mentioned any particular safety concerns with cyflufenamid nor did any commenters provide supporting information for the Agency to evaluate or on which the Agency could rely to support a finding on the petitioned- for tolerances. EPA recognizes that some individuals believe that pesticides should be banned on agricultural crops. The existing legal framework provided by section 408 of the Federal Food, Drug, and Cosmetic Act (FFDCA), however, states that tolerances may be set when persons seeking such tolerances or exemptions have demonstrated that the pesticide meets the safety standard imposed by that statute. EPA has assessed the effects of cyflufenamid on human health and determined that aggregate exposure to it will be safe. These comments provide no information to support an alternative conclusion. As noted in Unit III.C.4., Congress has directed EPA to consider the cumulative risk of pesticide residues with residues of ``other substances that have a common mechanism of toxicity.'' FFDCA section 408(b)(2)(D)(v). At this time, EPA has not concluded that cyflufenamid has a common mechanism of toxicity with any other pesticides. The petitioner has not provided any other information to support a different conclusion. D. Revisions to Petitioned-for Tolerances EPA is establishing tolerances that vary slightly from requests in the petition by adding another significant figure to the tolerance levels for subgroup 12-12A and group 8-10 and revising commodity term for hops to match the Agency's commodity vocabulary. V. Conclusion Therefore, tolerances are established for residues of cyflufenamid, in or on cherry crop subgroup 12-12A at 0.60 ppm; hop, dried cones at 5.0 ppm; and fruiting vegetable group 8-10 at 0.20 ppm; and the tolerance for residues in or on cucurbit vegetable group 9 is increased to 0.10 ppm. VI. Statutory and Executive Order Reviews This action establishes and amends tolerances under FFDCA section 408(d) in response to a petition submitted to the Agency. The Office of Management and Budget (OMB) has exempted these types of actions from review under Executive Order 12866, entitled ``Regulatory Planning and Review'' (58 FR 51735, October 4, 1993). Because this action has been exempted from review under Executive Order 12866, this action is not subject to Executive Order 13211, entitled ``Actions Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use'' (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled ``Protection of Children from Environmental Health Risks and Safety Risks'' (62 FR 19885, April 23, 1997)), or Executive Order 13771, entitled ``Reducing Regulations and Controlling Regulatory Costs'' (82 FR 9339, February 3, 2017). This action does not contain any information collections subject to OMB approval under the Paperwork Reduction Act (PRA) (44 U.S.C. 3501 et seq.), nor does it require any special considerations under Executive Order 12898, entitled ``Federal Actions to Address Environmental Justice in Minority Populations and Low-Income Populations'' (59 FR 7629, February 16, 1994). Since tolerances and exemptions that are established on the basis of a petition under FFDCA section 408(d), such as the tolerance in this final rule, do not require the issuance of a proposed rule, the requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et seq.), do not apply. This action directly regulates growers, food processors, food handlers, and food retailers, not States or tribes, nor does this action alter the relationships or distribution of power and responsibilities established by Congress in the preemption provisions of FFDCA section 408(n)(4). As such, the Agency has determined that this action will not have a substantial direct effect on States or tribal governments, on the relationship between the national government and the States or tribal governments, or on the distribution of power and responsibilities among the various levels of government or between the Federal Government and Indian tribes. Thus, the Agency has determined that Executive Order 13132, entitled ``Federalism'' (64 FR 43255, August 10, 1999) and Executive Order 13175, entitled ``Consultation and Coordination with Indian Tribal Governments'' (65 FR 67249, November 9, 2000) do not apply to this action. In addition, this action does not impose any enforceable duty or contain any unfunded mandate as described under Title II of the Unfunded Mandates Reform Act (UMRA) (2 U.S.C. 1501 et seq.). This action does not involve any technical standards that would require Agency consideration of voluntary consensus standards pursuant to section 12(d) of the National Technology Transfer and Advancement Act (NTTAA) (15 U.S.C. 272 note). [[Page 5717]] VII. Congressional Review Act Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.), EPA will submit a report containing this rule and other required information to the U.S. Senate, the U.S. House of Representatives, and the Comptroller General of the United States prior to publication of the rule in the Federal Register. This action is not a ``major rule'' as defined by 5 U.S.C. 804(2). List of Subjects in 40 CFR Part 180 Environmental protection, Administrative practice and procedure, Agricultural commodities, Pesticides and pests, Reporting and recordkeeping requirements. Dated: January 24, 2018. Michael Goodis, Director, Registration Division, Office of Pesticide Programs. Therefore, 40 CFR chapter I is amended as follows: PART 180--[AMENDED] 0 1. The authority citation for part 180 continues to read as follows: Authority: 21 U.S.C. 321(q), 346a and 371. 0 2. In Sec. 180.667, amend the table in paragraph (a) by: 0 i. Adding alphabetically the commodities ``Cherry subgroup 12-12A'', ``Hop, dried cones'', and ``Vegetable, fruiting, group 8-10'', and 0 ii. Revising the commodity ``Vegetable, cucurbit, group 9''. The additions and revisions read as follows: Sec. [emsp14]180.667 Cyflufenamid; tolerances for residues. (a) * * * ------------------------------------------------------------------------ Parts per Commodity million ------------------------------------------------------------------------ * * * * * Cherry subgroup 12-12A....................................... 0.60 * * * * * Hop, dried cones............................................. 5.0 Vegetable, cucurbit, group 9................................. 0.10 Vegetable, fruiting, group 8-10.............................. 0.20 ------------------------------------------------------------------------ * * * * * [FR Doc. 2018-02670 Filed 2-8-18; 8:45 am] BILLING CODE 6560-50-P
![Federal Register / Vol. 83, No. 28 / Friday, February 9, 2018 / Rules and Regulations 5711
also available for inspection at the and effective September 15, 2017. FAA PART 71—DESIGNATION OF CLASS A,
National Archives and Records Order 7400.11B is publicly available as B, C, D, AND E AIRSPACE AREAS; AIR
Administration (NARA). For listed in the ADDRESSES section of this TRAFFIC SERVICE ROUTES; AND
information on the availability of FAA document. FAA Order 7400.11B lists REPORTING POINTS
Order 7400.11B at NARA, call (202) Class A, B, C, D, and E airspace areas,
741–6030, or go to https:// air traffic service routes, and reporting ■ 1. The authority citation for part 71
www.archives.gov/federal-register/cfr/ points. continues to read as follows:
ibr-locations.html. Authority: 49 U.S.C. 106(f), 106(g); 40103,
FAA Order 7400.11, Airspace The Rule
40113, 40120; E.O. 10854, 24 FR 9565, 3 CFR,
Designations and Reporting Points, is This amendment to title 14, Code of 1959–1963 Comp., p. 389.
published yearly and effective on Federal Regulations (14 CFR) part 71
September 15. removes the Class E airspace area § 71.1 [Amended]
FOR FURTHER INFORMATION CONTACT: extending upward from 700 feet above ■ 2. The incorporation by reference in
Jeffrey Claypool, Federal Aviation the surface within a 6.9-mile radius of 14 CFR 71.1 of FAA Order 7400.11B,
Administration, Operations Support Carter Airport, Pulaski, WI. Airspace Designations and Reporting
Group, Central Service Center, 10101 This action is necessary due to the Points, dated August 3, 2017, and
Hillwood Parkway, Fort Worth, TX, cancellation of the instrument effective September 15, 2017, is
76177; telephone (817) 222–5711. procedures at Carter Airport. The amended as follows:
SUPPLEMENTARY INFORMATION: removal of these procedures results in
Paragraph 6005 Class E Airspace Areas
the airport no longer qualifying for Extending Upward From 700 Feet or More
Authority for This Rulemaking controlled airspace. Above the Surface of the Earth.
The FAA’s authority to issue rules
Regulatory Notices and Analyses * * * * *
regarding aviation safety is found in
Title 49 of the United States Code. The FAA has determined that this AGL WI E5 Pulaski, WI [Removed]
Subtitle I, Section 106 describes the regulation only involves an established
body of technical regulations for which Issued in Fort Worth, Texas, on January 29,
authority of the FAA Administrator. 2018.
Subtitle VII, Aviation Programs, frequent and routine amendments are
necessary to keep them operationally Christopher L. Southerland,
describes in more detail the scope of the
agency’s authority. This rulemaking is current, is non-controversial and Acting Manager, Operations Support Group,
unlikely to result in adverse or negative ATO Central Service Center.
promulgated under the authority
comments. It, therefore: (1) Is not a [FR Doc. 2018–02137 Filed 2–8–18; 8:45 am]
described in Subtitle VII, Part A,
Subpart I, Section 40103. Under that ‘‘significant regulatory action’’ under BILLING CODE 4910–13–P
section, the FAA is charged with Executive Order 12866; (2) is not a
prescribing regulations to assign the use ‘‘significant rule’’ under DOT
of airspace necessary to ensure the Regulatory Policies and Procedures (44 ENVIRONMENTAL PROTECTION
safety of aircraft and the efficient use of FR 11034; February 26, 1979); and (3) AGENCY
airspace. This regulation is within the does not warrant preparation of a
scope of that authority as it supports the regulatory evaluation as the anticipated 40 CFR Part 180
removal of Class E airspace extending impact is so minimal. Since this is a [EPA–HQ–OPP–2016–0649; FRL–9972–61]
upward from 700 feet above the surface routine matter that only affects air traffic
at Carter Airport, Pulaski, WI. procedures and air navigation, it is Cyflufenamid; Pesticide Tolerances
certified that this rule, when
History AGENCY: Environmental Protection
promulgated, does not have a significant
The FAA published a notice of Agency (EPA).
economic impact on a substantial
proposed rulemaking in the Federal ACTION: Final rule.
number of small entities under the
Register (82 FR 45749; October 2, 2017) criteria of the Regulatory Flexibility Act. SUMMARY: This regulation establishes
for Docket No. FAA–2017–0818 to tolerances for residues of cyflufenamid
remove Class E airspace extending Environmental Review
in or on cherry crop subgroup 12–12A,
upward from 700 feet above the surface The FAA has determined that this hops dried cones, and fruiting vegetable
at Carter Airport, Pulaski, WI. Interested action qualifies for categorical exclusion crop group 8–10; and amends the
parties were invited to participate in under the National Environmental tolerance for cucurbit vegetable crop
this rulemaking effort by submitting Policy Act in accordance with FAA group 9. Nisso America, on behalf of
written comments on the proposal to the Order 1050.1F, ‘‘Environmental Nippon Soda Co., Ltd. requested these
FAA. No comments were received. Impacts: Policies and Procedures,’’ tolerances under the Federal Food,
Class E airspace designations are paragraph 5–6.5.a. This airspace action Drug, and Cosmetic Act (FFDCA).
published in paragraph 6005 of FAA is not expected to cause any potentially
Order 7400.11B, dated August 3, 2017, DATES: This regulation is effective
significant environmental impacts, and
and effective September 15, 2017, which no extraordinary circumstances exist February 9, 2018. Objections and
is incorporated by reference in 14 CFR that warrant preparation of an requests for hearings must be received
71.1. The Class E airspace designations environmental assessment. on or before April 10, 2018, and must
listed in this document will be be filed in accordance with the
published subsequently in the Order. Lists of Subjects in 14 CFR Part 71 instructions provided in 40 CFR part
sradovich on DSK3GMQ082PROD with RULES
Airspace, Incorporation by reference, 178 (see also Unit I.C. of the
Availability and Summary of SUPPLEMENTARY INFORMATION).
Navigation (air).
Documents for Incorporation by ADDRESSES: The docket for this action,
Reference Adoption of the Amendment identified by docket identification (ID)
This document amends FAA Order In consideration of the foregoing, the number EPA–HQ–OPP–2016–0649, is
7400.11B, Airspace Designations and Federal Aviation Administration available at http://www.regulations.gov
Reporting Points, dated August 3, 2017, amends 14 CFR part 71 as follows: or at the Office of Pesticide Programs
VerDate Sep<11>2014 15:59 Feb 08, 2018 Jkt 244001 PO 00000 Frm 00031 Fmt 4700 Sfmt 4700 E:\FR\FM\09FER1.SGM 09FER1](https://thefederalregister.org/doc/83_FR_5739/page/1.svg)
![Federal Register / Vol. 83, No. 28 / Friday, February 9, 2018 / Rules and Regulations 5717
VII. Congressional Review Act ENVIRONMENTAL PROTECTION determine whether this document
AGENCY applies to them. Potentially affected
Pursuant to the Congressional Review entities may include:
Act (5 U.S.C. 801 et seq.), EPA will 40 CFR Part 180 • Crop production (NAICS code 111).
submit a report containing this rule and • Animal production (NAICS code
[EPA–HQ–OPP–2016–0681; FRL–9972–69]
other required information to the U.S. 112).
Senate, the U.S. House of Zoxamide; Pesticide Tolerances • Food manufacturing (NAICS code
Representatives, and the Comptroller 311).
General of the United States prior to AGENCY: Environmental Protection • Pesticide manufacturing (NAICS
publication of the rule in the Federal Agency (EPA). code 32532).
Register. This action is not a ‘‘major ACTION: Final rule. B. How can I get electronic access to
rule’’ as defined by 5 U.S.C. 804(2). other related information?
SUMMARY: This regulation establishes
List of Subjects in 40 CFR Part 180 tolerances for residues of zoxamide in or You may access a frequently updated
on banana. Gowan Company, LLC electronic version of EPA’s tolerance
Environmental protection, requested these tolerances under the regulations at 40 CFR part 180 through
Administrative practice and procedure, Federal Food, Drug, and Cosmetic Act the Government Printing Office’s e-CFR
Agricultural commodities, Pesticides (FFDCA). site at http://www.ecfr.gov/cgi-bin/text-
and pests, Reporting and recordkeeping idx?&c=ecfr&tpl=/ecfrbrowse/Title40/
DATES: This regulation is effective
requirements. 40tab_02.tpl.
February 9, 2018. Objections and
Dated: January 24, 2018. requests for hearings must be received C. How can I file an objection or hearing
Michael Goodis, on or before April 10, 2018, and must request?
Director, Registration Division, Office of be filed in accordance with the Under FFDCA section 408(g), 21
Pesticide Programs. instructions provided in 40 CFR part U.S.C. 346a, any person may file an
178 (see also Unit I.C. of the objection to any aspect of this regulation
Therefore, 40 CFR chapter I is SUPPLEMENTARY INFORMATION).
amended as follows: and may also request a hearing on those
ADDRESSES: The docket for this action, objections. You must file your objection
PART 180—[AMENDED] identified by docket identification (ID) or request a hearing on this regulation
number EPA–HQ–OPP–2016–0681, is in accordance with the instructions
available at http://www.regulations.gov provided in 40 CFR part 178. To ensure
■ 1. The authority citation for part 180
or at the Office of Pesticide Programs proper receipt by EPA, you must
continues to read as follows:
Regulatory Public Docket (OPP Docket) identify docket ID number EPA–HQ–
Authority: 21 U.S.C. 321(q), 346a and 371. in the Environmental Protection Agency OPP–2016–0681 in the subject line on
■ 2. In § 180.667, amend the table in Docket Center (EPA/DC), West William the first page of your submission. All
paragraph (a) by: Jefferson Clinton Bldg., Rm. 3334, 1301 objections and requests for a hearing
Constitution Ave. NW, Washington, DC must be in writing, and must be
■ i. Adding alphabetically the 20460–0001. The Public Reading Room received by the Hearing Clerk on or
commodities ‘‘Cherry subgroup 12– is open from 8:30 a.m. to 4:30 p.m., before April 10, 2018. Addresses for
12A’’, ‘‘Hop, dried cones’’, and Monday through Friday, excluding legal mail and hand delivery of objections
‘‘Vegetable, fruiting, group 8–10’’, and holidays. The telephone number for the and hearing requests are provided in 40
■ ii. Revising the commodity Public Reading Room is (202) 566–1744, CFR 178.25(b).
‘‘Vegetable, cucurbit, group 9’’. and the telephone number for the OPP In addition to filing an objection or
Docket is (703) 305–5805. Please review hearing request with the Hearing Clerk
The additions and revisions read as the visitor instructions and additional
follows: as described in 40 CFR part 178, please
information about the docket available submit a copy of the filing (excluding
§ 180.667 Cyflufenamid; tolerances for at http://www.epa.gov/dockets. any Confidential Business Information
residues. FOR FURTHER INFORMATION CONTACT: (CBI)) for inclusion in the public docket.
Michael L. Goodis, P.E., Director, Information not marked confidential
(a) * * * Registration Division (7505P), Office of pursuant to 40 CFR part 2 may be
Pesticide Programs, Environmental disclosed publicly by EPA without prior
Parts per
Commodity million Protection Agency, 1200 Pennsylvania notice. Submit the non-CBI copy of your
Ave. NW, Washington, DC 20460–0001; objection or hearing request, identified
main telephone number: (703) 305– by docket ID number EPA–HQ–OPP–
* * * * * 7090; email address: RDFRNotices@ 2016–0681, by one of the following
epa.gov. methods:
Cherry subgroup 12–12A ............. 0.60 • Federal eRulemaking Portal: http://
SUPPLEMENTARY INFORMATION:
www.regulations.gov. Follow the online
* * * * * I. General Information instructions for submitting comments.
Do not submit electronically any
A. Does this action apply to me?
Hop, dried cones .......................... 5.0 information you consider to be CBI or
Vegetable, cucurbit, group 9 ........ 0.10 You may be potentially affected by other information whose disclosure is
sradovich on DSK3GMQ082PROD with RULES
Vegetable, fruiting, group 8–10 .... 0.20 this action if you are an agricultural restricted by statute.
producer, food manufacturer, or • Mail: OPP Docket, Environmental
* * * * * pesticide manufacturer. The following Protection Agency Docket Center (EPA/
[FR Doc. 2018–02670 Filed 2–8–18; 8:45 am] list of North American Industrial DC), (28221T), 1200 Pennsylvania Ave.
BILLING CODE 6560–50–P Classification System (NAICS) codes is NW, Washington, DC 20460–0001.
not intended to be exhaustive, but rather • Hand Delivery: To make special
provides a guide to help readers arrangements for hand delivery or
VerDate Sep<11>2014 15:59 Feb 08, 2018 Jkt 244001 PO 00000 Frm 00037 Fmt 4700 Sfmt 4700 E:\FR\FM\09FER1.SGM 09FER1](https://thefederalregister.org/doc/83_FR_5739/page/7.svg)
Document Created: 2018-02-09 00:12:06
Document Modified: 2018-02-09 00:12:06
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Rules and Regulations | |
| Action | Final rule. | |
| Dates | This regulation is effective February 9, 2018. Objections and requests for hearings must be received on or before April 10, 2018, and must be filed in accordance with the instructions provided in 40 CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION). | |
| Contact | Michael Goodis, Registration Division (7505P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; main telephone | |
| FR Citation | 83 FR 5711 | |
| CFR Associated | Environmental Protection; Administrative Practice and Procedure; Agricultural Commodities; Pesticides and Pests and Reporting and Recordkeeping Requirements |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR